Hyderabad-based Standard Glass Lining Technology Limited, a key player in specialized engineering equipment for the pharmaceutical and chemical industries, just secured ₹40 crore in pre-IPO funding from Singapore-based Amansa Investments. The deal was finalized through a private placement of 28,57,142 equity shares at ₹140 per share, marking a premium of ₹130. The IPO, priced at a face value of ₹10 per equity share, is projected to raise ₹250 crore through new issuance, along with an offer for sale of 18,444,000 equity shares by promoters and other stakeholders. With SEBI’s final observation in October 2024, Standard Glass is ready to enter the public markets.Known for its turnkey solutions, the company’s product portfolio spans services essential for pharmaceutical and chemical production. By June 30, 2024, its client list included 30 of the approximately 80 pharma and chemical companies in the NSE 500.